Loading…

Base excision by thymine DNA glycosylase mediates DNA-directed cytotoxicity of 5-fluorouracil

5-Fluorouracil (5-FU), a chemotherapeutic drug commonly used in cancer treatment, imbalances nucleotide pools, thereby favoring misincorporation of uracil and 5-FU into genomic DNA. The processing of these bases by DNA repair activities was proposed to cause DNA-directed cytotoxicity, but the underl...

Full description

Saved in:
Bibliographic Details
Published in:PLoS biology 2009-04, Vol.7 (4), p.e91-e1000091
Main Authors: Kunz, Christophe, Focke, Frauke, Saito, Yusuke, Schuermann, David, Lettieri, Teresa, Selfridge, Jim, Schär, Primo
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c832t-8da944ee2dff111d7bf680580f4a17e80e607c00f5dbaf6f7b92ea35eaebf5913
cites cdi_FETCH-LOGICAL-c832t-8da944ee2dff111d7bf680580f4a17e80e607c00f5dbaf6f7b92ea35eaebf5913
container_end_page e1000091
container_issue 4
container_start_page e91
container_title PLoS biology
container_volume 7
creator Kunz, Christophe
Focke, Frauke
Saito, Yusuke
Schuermann, David
Lettieri, Teresa
Selfridge, Jim
Schär, Primo
description 5-Fluorouracil (5-FU), a chemotherapeutic drug commonly used in cancer treatment, imbalances nucleotide pools, thereby favoring misincorporation of uracil and 5-FU into genomic DNA. The processing of these bases by DNA repair activities was proposed to cause DNA-directed cytotoxicity, but the underlying mechanisms have not been resolved. In this study, we investigated a possible role of thymine DNA glycosylase (TDG), one of four mammalian uracil DNA glycosylases (UDGs), in the cellular response to 5-FU. Using genetic and biochemical tools, we found that inactivation of TDG significantly increases resistance of both mouse and human cancer cells towards 5-FU. We show that excision of DNA-incorporated 5-FU by TDG generates persistent DNA strand breaks, delays S-phase progression, and activates DNA damage signaling, and that the repair of 5-FU-induced DNA strand breaks is more efficient in the absence of TDG. Hence, excision of 5-FU by TDG, but not by other UDGs (UNG2 and SMUG1), prevents efficient downstream processing of the repair intermediate, thereby mediating DNA-directed cytotoxicity. The status of TDG expression in a cancer is therefore likely to determine its response to 5-FU-based chemotherapy.
doi_str_mv 10.1371/journal.pbio.1000091
format article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1295105739</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A199398038</galeid><doaj_id>oai_doaj_org_article_4165cec158c9407b8bacefe22d778183</doaj_id><sourcerecordid>A199398038</sourcerecordid><originalsourceid>FETCH-LOGICAL-c832t-8da944ee2dff111d7bf680580f4a17e80e607c00f5dbaf6f7b92ea35eaebf5913</originalsourceid><addsrcrecordid>eNqVkl2L1DAUhoso7rr6D0QLguBFxyRtmuRmYVy_BpZd8OtOQpqezGboNGOSyvTfmzpVd8ALTS4SznnOm8Obk2WPMVrgkuGXGzf4XnWLXWPdAqO0BL6TnWJa0YJxTu_eup9kD0LYIESIIPx-doJFhQirxGn29ZUKkMNe22BdnzdjHm_Gre0hf321zNfdqF0Yu4nZQmtVhDAlitZ60BHaXI_RRbe32sYxdyanhekG51NvStvuYXbPqC7Ao_k8yz6_ffPp4n1xef1udbG8LDQvSSx4q0RVAZDWGIxxyxpTc0Q5MpXCDDiCGjGNkKFto0xtWCMIqJKCgsZQgcuz7OlBd9e5IGdngsREUIwoK0UiVgeidWojd95ulR-lU1b-DDi_lspHqzuQFa6pBo0p18km1vBGaTBASMsYx7xMWufza0OTXNHQR6-6I9HjTG9v5Np9l6RmmNYoCTyfBbz7NkCIcmuDhq5TPbghSIKoIJUgCXx2ANcqNWZ745KenmC5xEKUgqOSJ2rxFyrtFrZWux6MTfGjghdHBYmJsI9rNYQgVx8__Ad79e_s9Zdjtjqw2rsQPJjf_mEkpwH_9Y1yGnA5D3gqe3Lb-z9F80SXPwAfo_d4</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20592492</pqid></control><display><type>article</type><title>Base excision by thymine DNA glycosylase mediates DNA-directed cytotoxicity of 5-fluorouracil</title><source>PubMed Central Free</source><source>Publicly Available Content Database</source><creator>Kunz, Christophe ; Focke, Frauke ; Saito, Yusuke ; Schuermann, David ; Lettieri, Teresa ; Selfridge, Jim ; Schär, Primo</creator><contributor>Haber, James E</contributor><creatorcontrib>Kunz, Christophe ; Focke, Frauke ; Saito, Yusuke ; Schuermann, David ; Lettieri, Teresa ; Selfridge, Jim ; Schär, Primo ; Haber, James E</creatorcontrib><description>5-Fluorouracil (5-FU), a chemotherapeutic drug commonly used in cancer treatment, imbalances nucleotide pools, thereby favoring misincorporation of uracil and 5-FU into genomic DNA. The processing of these bases by DNA repair activities was proposed to cause DNA-directed cytotoxicity, but the underlying mechanisms have not been resolved. In this study, we investigated a possible role of thymine DNA glycosylase (TDG), one of four mammalian uracil DNA glycosylases (UDGs), in the cellular response to 5-FU. Using genetic and biochemical tools, we found that inactivation of TDG significantly increases resistance of both mouse and human cancer cells towards 5-FU. We show that excision of DNA-incorporated 5-FU by TDG generates persistent DNA strand breaks, delays S-phase progression, and activates DNA damage signaling, and that the repair of 5-FU-induced DNA strand breaks is more efficient in the absence of TDG. Hence, excision of 5-FU by TDG, but not by other UDGs (UNG2 and SMUG1), prevents efficient downstream processing of the repair intermediate, thereby mediating DNA-directed cytotoxicity. The status of TDG expression in a cancer is therefore likely to determine its response to 5-FU-based chemotherapy.</description><identifier>ISSN: 1545-7885</identifier><identifier>ISSN: 1544-9173</identifier><identifier>EISSN: 1545-7885</identifier><identifier>DOI: 10.1371/journal.pbio.1000091</identifier><identifier>PMID: 19402749</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Animals ; Antimetabolites, Antineoplastic - pharmacology ; Antimetabolites, Antineoplastic - therapeutic use ; Apoptosis ; Binding sites ; Biochemistry ; Cancer ; Cancer therapies ; Cell Biology ; Cell Cycle - genetics ; Cell Death - drug effects ; Cell Line, Tumor ; Cell-mediated cytotoxicity ; Cytotoxicity ; Deoxyribonucleic acid ; Developmental Biology ; DNA ; DNA Damage ; DNA glycosylases ; DNA Glycosylases - metabolism ; DNA Repair - drug effects ; Experiments ; Fluorouracil ; Fluorouracil - pharmacology ; Fluorouracil - therapeutic use ; Genetics and Genomics ; Kinases ; Metabolites ; Mice ; Molecular Biology ; Neoplasms - drug therapy ; Neoplasms - genetics ; Physiological aspects ; Proteins ; Signal Transduction ; Thymine DNA Glycosylase - metabolism ; Uracil-DNA Glycosidase - metabolism</subject><ispartof>PLoS biology, 2009-04, Vol.7 (4), p.e91-e1000091</ispartof><rights>COPYRIGHT 2009 Public Library of Science</rights><rights>2009 Kunz et al. 2009</rights><rights>2009 Kunz et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Kunz C, Focke F, Saito Y, Schuermann D, Lettieri T, et al. (2009) Base Excision by Thymine DNA Glycosylase Mediates DNA-Directed Cytotoxicity of 5-Fluorouracil. PLoS Biol 7(4): e1000091. doi:10.1371/journal.pbio.1000091</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c832t-8da944ee2dff111d7bf680580f4a17e80e607c00f5dbaf6f7b92ea35eaebf5913</citedby><cites>FETCH-LOGICAL-c832t-8da944ee2dff111d7bf680580f4a17e80e607c00f5dbaf6f7b92ea35eaebf5913</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2671560/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2671560/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,37013,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19402749$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Haber, James E</contributor><creatorcontrib>Kunz, Christophe</creatorcontrib><creatorcontrib>Focke, Frauke</creatorcontrib><creatorcontrib>Saito, Yusuke</creatorcontrib><creatorcontrib>Schuermann, David</creatorcontrib><creatorcontrib>Lettieri, Teresa</creatorcontrib><creatorcontrib>Selfridge, Jim</creatorcontrib><creatorcontrib>Schär, Primo</creatorcontrib><title>Base excision by thymine DNA glycosylase mediates DNA-directed cytotoxicity of 5-fluorouracil</title><title>PLoS biology</title><addtitle>PLoS Biol</addtitle><description>5-Fluorouracil (5-FU), a chemotherapeutic drug commonly used in cancer treatment, imbalances nucleotide pools, thereby favoring misincorporation of uracil and 5-FU into genomic DNA. The processing of these bases by DNA repair activities was proposed to cause DNA-directed cytotoxicity, but the underlying mechanisms have not been resolved. In this study, we investigated a possible role of thymine DNA glycosylase (TDG), one of four mammalian uracil DNA glycosylases (UDGs), in the cellular response to 5-FU. Using genetic and biochemical tools, we found that inactivation of TDG significantly increases resistance of both mouse and human cancer cells towards 5-FU. We show that excision of DNA-incorporated 5-FU by TDG generates persistent DNA strand breaks, delays S-phase progression, and activates DNA damage signaling, and that the repair of 5-FU-induced DNA strand breaks is more efficient in the absence of TDG. Hence, excision of 5-FU by TDG, but not by other UDGs (UNG2 and SMUG1), prevents efficient downstream processing of the repair intermediate, thereby mediating DNA-directed cytotoxicity. The status of TDG expression in a cancer is therefore likely to determine its response to 5-FU-based chemotherapy.</description><subject>Animals</subject><subject>Antimetabolites, Antineoplastic - pharmacology</subject><subject>Antimetabolites, Antineoplastic - therapeutic use</subject><subject>Apoptosis</subject><subject>Binding sites</subject><subject>Biochemistry</subject><subject>Cancer</subject><subject>Cancer therapies</subject><subject>Cell Biology</subject><subject>Cell Cycle - genetics</subject><subject>Cell Death - drug effects</subject><subject>Cell Line, Tumor</subject><subject>Cell-mediated cytotoxicity</subject><subject>Cytotoxicity</subject><subject>Deoxyribonucleic acid</subject><subject>Developmental Biology</subject><subject>DNA</subject><subject>DNA Damage</subject><subject>DNA glycosylases</subject><subject>DNA Glycosylases - metabolism</subject><subject>DNA Repair - drug effects</subject><subject>Experiments</subject><subject>Fluorouracil</subject><subject>Fluorouracil - pharmacology</subject><subject>Fluorouracil - therapeutic use</subject><subject>Genetics and Genomics</subject><subject>Kinases</subject><subject>Metabolites</subject><subject>Mice</subject><subject>Molecular Biology</subject><subject>Neoplasms - drug therapy</subject><subject>Neoplasms - genetics</subject><subject>Physiological aspects</subject><subject>Proteins</subject><subject>Signal Transduction</subject><subject>Thymine DNA Glycosylase - metabolism</subject><subject>Uracil-DNA Glycosidase - metabolism</subject><issn>1545-7885</issn><issn>1544-9173</issn><issn>1545-7885</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNqVkl2L1DAUhoso7rr6D0QLguBFxyRtmuRmYVy_BpZd8OtOQpqezGboNGOSyvTfmzpVd8ALTS4SznnOm8Obk2WPMVrgkuGXGzf4XnWLXWPdAqO0BL6TnWJa0YJxTu_eup9kD0LYIESIIPx-doJFhQirxGn29ZUKkMNe22BdnzdjHm_Gre0hf321zNfdqF0Yu4nZQmtVhDAlitZ60BHaXI_RRbe32sYxdyanhekG51NvStvuYXbPqC7Ao_k8yz6_ffPp4n1xef1udbG8LDQvSSx4q0RVAZDWGIxxyxpTc0Q5MpXCDDiCGjGNkKFto0xtWCMIqJKCgsZQgcuz7OlBd9e5IGdngsREUIwoK0UiVgeidWojd95ulR-lU1b-DDi_lspHqzuQFa6pBo0p18km1vBGaTBASMsYx7xMWufza0OTXNHQR6-6I9HjTG9v5Np9l6RmmNYoCTyfBbz7NkCIcmuDhq5TPbghSIKoIJUgCXx2ANcqNWZ745KenmC5xEKUgqOSJ2rxFyrtFrZWux6MTfGjghdHBYmJsI9rNYQgVx8__Ad79e_s9Zdjtjqw2rsQPJjf_mEkpwH_9Y1yGnA5D3gqe3Lb-z9F80SXPwAfo_d4</recordid><startdate>20090401</startdate><enddate>20090401</enddate><creator>Kunz, Christophe</creator><creator>Focke, Frauke</creator><creator>Saito, Yusuke</creator><creator>Schuermann, David</creator><creator>Lettieri, Teresa</creator><creator>Selfridge, Jim</creator><creator>Schär, Primo</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISN</scope><scope>ISR</scope><scope>7TM</scope><scope>5PM</scope><scope>DOA</scope><scope>CZG</scope></search><sort><creationdate>20090401</creationdate><title>Base excision by thymine DNA glycosylase mediates DNA-directed cytotoxicity of 5-fluorouracil</title><author>Kunz, Christophe ; Focke, Frauke ; Saito, Yusuke ; Schuermann, David ; Lettieri, Teresa ; Selfridge, Jim ; Schär, Primo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c832t-8da944ee2dff111d7bf680580f4a17e80e607c00f5dbaf6f7b92ea35eaebf5913</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Animals</topic><topic>Antimetabolites, Antineoplastic - pharmacology</topic><topic>Antimetabolites, Antineoplastic - therapeutic use</topic><topic>Apoptosis</topic><topic>Binding sites</topic><topic>Biochemistry</topic><topic>Cancer</topic><topic>Cancer therapies</topic><topic>Cell Biology</topic><topic>Cell Cycle - genetics</topic><topic>Cell Death - drug effects</topic><topic>Cell Line, Tumor</topic><topic>Cell-mediated cytotoxicity</topic><topic>Cytotoxicity</topic><topic>Deoxyribonucleic acid</topic><topic>Developmental Biology</topic><topic>DNA</topic><topic>DNA Damage</topic><topic>DNA glycosylases</topic><topic>DNA Glycosylases - metabolism</topic><topic>DNA Repair - drug effects</topic><topic>Experiments</topic><topic>Fluorouracil</topic><topic>Fluorouracil - pharmacology</topic><topic>Fluorouracil - therapeutic use</topic><topic>Genetics and Genomics</topic><topic>Kinases</topic><topic>Metabolites</topic><topic>Mice</topic><topic>Molecular Biology</topic><topic>Neoplasms - drug therapy</topic><topic>Neoplasms - genetics</topic><topic>Physiological aspects</topic><topic>Proteins</topic><topic>Signal Transduction</topic><topic>Thymine DNA Glycosylase - metabolism</topic><topic>Uracil-DNA Glycosidase - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kunz, Christophe</creatorcontrib><creatorcontrib>Focke, Frauke</creatorcontrib><creatorcontrib>Saito, Yusuke</creatorcontrib><creatorcontrib>Schuermann, David</creatorcontrib><creatorcontrib>Lettieri, Teresa</creatorcontrib><creatorcontrib>Selfridge, Jim</creatorcontrib><creatorcontrib>Schär, Primo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Canada</collection><collection>Science in Context</collection><collection>Nucleic Acids Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><collection>PLoS Biology</collection><jtitle>PLoS biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kunz, Christophe</au><au>Focke, Frauke</au><au>Saito, Yusuke</au><au>Schuermann, David</au><au>Lettieri, Teresa</au><au>Selfridge, Jim</au><au>Schär, Primo</au><au>Haber, James E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Base excision by thymine DNA glycosylase mediates DNA-directed cytotoxicity of 5-fluorouracil</atitle><jtitle>PLoS biology</jtitle><addtitle>PLoS Biol</addtitle><date>2009-04-01</date><risdate>2009</risdate><volume>7</volume><issue>4</issue><spage>e91</spage><epage>e1000091</epage><pages>e91-e1000091</pages><issn>1545-7885</issn><issn>1544-9173</issn><eissn>1545-7885</eissn><abstract>5-Fluorouracil (5-FU), a chemotherapeutic drug commonly used in cancer treatment, imbalances nucleotide pools, thereby favoring misincorporation of uracil and 5-FU into genomic DNA. The processing of these bases by DNA repair activities was proposed to cause DNA-directed cytotoxicity, but the underlying mechanisms have not been resolved. In this study, we investigated a possible role of thymine DNA glycosylase (TDG), one of four mammalian uracil DNA glycosylases (UDGs), in the cellular response to 5-FU. Using genetic and biochemical tools, we found that inactivation of TDG significantly increases resistance of both mouse and human cancer cells towards 5-FU. We show that excision of DNA-incorporated 5-FU by TDG generates persistent DNA strand breaks, delays S-phase progression, and activates DNA damage signaling, and that the repair of 5-FU-induced DNA strand breaks is more efficient in the absence of TDG. Hence, excision of 5-FU by TDG, but not by other UDGs (UNG2 and SMUG1), prevents efficient downstream processing of the repair intermediate, thereby mediating DNA-directed cytotoxicity. The status of TDG expression in a cancer is therefore likely to determine its response to 5-FU-based chemotherapy.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>19402749</pmid><doi>10.1371/journal.pbio.1000091</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1545-7885
ispartof PLoS biology, 2009-04, Vol.7 (4), p.e91-e1000091
issn 1545-7885
1544-9173
1545-7885
language eng
recordid cdi_plos_journals_1295105739
source PubMed Central Free; Publicly Available Content Database
subjects Animals
Antimetabolites, Antineoplastic - pharmacology
Antimetabolites, Antineoplastic - therapeutic use
Apoptosis
Binding sites
Biochemistry
Cancer
Cancer therapies
Cell Biology
Cell Cycle - genetics
Cell Death - drug effects
Cell Line, Tumor
Cell-mediated cytotoxicity
Cytotoxicity
Deoxyribonucleic acid
Developmental Biology
DNA
DNA Damage
DNA glycosylases
DNA Glycosylases - metabolism
DNA Repair - drug effects
Experiments
Fluorouracil
Fluorouracil - pharmacology
Fluorouracil - therapeutic use
Genetics and Genomics
Kinases
Metabolites
Mice
Molecular Biology
Neoplasms - drug therapy
Neoplasms - genetics
Physiological aspects
Proteins
Signal Transduction
Thymine DNA Glycosylase - metabolism
Uracil-DNA Glycosidase - metabolism
title Base excision by thymine DNA glycosylase mediates DNA-directed cytotoxicity of 5-fluorouracil
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T01%3A44%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Base%20excision%20by%20thymine%20DNA%20glycosylase%20mediates%20DNA-directed%20cytotoxicity%20of%205-fluorouracil&rft.jtitle=PLoS%20biology&rft.au=Kunz,%20Christophe&rft.date=2009-04-01&rft.volume=7&rft.issue=4&rft.spage=e91&rft.epage=e1000091&rft.pages=e91-e1000091&rft.issn=1545-7885&rft.eissn=1545-7885&rft_id=info:doi/10.1371/journal.pbio.1000091&rft_dat=%3Cgale_plos_%3EA199398038%3C/gale_plos_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c832t-8da944ee2dff111d7bf680580f4a17e80e607c00f5dbaf6f7b92ea35eaebf5913%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=20592492&rft_id=info:pmid/19402749&rft_galeid=A199398038&rfr_iscdi=true